Evidence map›Paper›PMID 23260059›Full record

ArticleEmerging infectious diseases2013

Seroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore.

James M Trauer, Don Bandaranayake, Robert Booy, Mark I Chen, Michelle Cretikos, Gary K Dowse, Dominic E Dwyer, Michael E Greenberg, Q Sue Huang, Gulam Khandaker and 7 more

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

James M TrauerMelbourne Sleep Disorders Centre, East Melbourne, Victoria, Australia. james@msdc.com.au
Don Bandaranayake
Robert Booy
Mark I Chen
Michelle Cretikos
Gary K Dowse
Dominic E Dwyer
Michael E Greenberg
Q Sue Huang
Gulam Khandaker
Jen Kok
Karen L Laurie
Vernon J Lee
Jodie McVernon
Scott Walter
Peter G Markey
Australia, New Zealand and Singapore Pandemic Serosurveillance Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To estimate population attack rates of influenza A(H1N1)pdm2009 in the Southern Hemisphere during June-August 2009, we conducted several serologic studies. We pooled individual-level data from studies using hemagglutination inhibition assays performed in Australia, New Zealand, and Singapore. We determined seropositive proportions (titer ≥40) for each study region by age-group and sex in pre- and postpandemic phases, as defined by jurisdictional notification data. After exclusions, the pooled database consisted of, 4,414 prepandemic assays and 7,715 postpandemic assays. In the prepandemic phase, older age groups showed greater seropositive proportions, with age-standardized, community-based proportions ranging from 3.5% in Singapore to 11.9% in New Zealand. In the postpandemic phase, seropositive proportions ranged from 17.5% in Singapore to 30.8% in New Zealand, with highest proportions seen in school-aged children. Pregnancy and residential care were associated with lower postpandemic seropositivity, whereas Aboriginal and Torres Strait Islander Australians and Pacific Peoples of New Zealand had greater postpandemic seropositivity.

Indexed as

PandemicsAdolescentAdultAgedAged, 80 and overAge FactorsAntibodies, ViralAustraliaAustralian Aboriginal and Torres Strait Islander PeoplesChildChild, PreschoolFemaleHemagglutination Inhibition TestsHumansIncidenceInfantAntibodies, Viral

Identifiers

PMID23260059
PMCPMC3557971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.